Teva, Mylan launch Viagra generics in Europe

Erectile dysfunction drug's patents expire in 2019, 2020 in United States, according to FDA

NEW YORK — Teva Pharmaceutical Industries and Mylan have launched generic versions of Pfizer's Viagra in nearly a dozen European countries, the two companies said.

Teva, based in Jerusalem, announced the launch of generic sildenafil tablets in Germany, the United Kingdom, Italy, the Netherlands, Switzerland, Ireland, Austria, Belgium and Denmark. The company already markets generic versions of the erectile dysfunction drug in Spain and Canada.

Meanwhile, Pittsburgh-based Mylan launched its own generic version of the drug in France, the United Kingdom, Ireland, Italy, Belgium, Slovakia, Germany, Denmark, the Czech Republic, Spain and the Netherlands.

In the 11 countries in which Mylan is launching the drug, Viagra had sales of $310.4 million during the 12-month period that ended in March, according to IMS Health.

 

Login or Register to post a comment.